Showing results (71-80 of 379) with videos related to

Sort By:
Pageof 38
The British Journal of Dermatology|July 27, 2025
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trialJürgen C Becker, Anja H Gesierich, Ulrike Leiter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 22, 2012
Current advances and perspectives in the treatment of advanced melanomaElisabeth Livingstone, Lisa Zimmer, Julia Vaubel, et al.
Chinese Clinical Oncology|April 6, 2015
BRAF, MEK and KIT inhibitors for melanoma: adverse events and their managementElisabeth Livingstone, Lisa Zimmer, Julia Vaubel, et al.
Expert Opinion on Investigational Drugs|October 15, 2010
PLX4032: does it keep its promise for metastatic melanoma treatment?Elisabeth Livingstone, Lisa Zimmer, Sarah Piel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 11, 2012
Side effects of systemic oncological therapies in dermatologyLisa Zimmer, Julia Vaubel, Elisabeth Livingstone, et al.
Cancers|October 14, 2022
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future PerspectivesMarkus V Heppt, Christoffer Gebhardt, Jessica C Hassel, et al.
Melanoma Research|February 28, 2018
STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-αDevayani Machiraju, Iris Moll, Christoffer Gebhardt, et al.
Experimental Dermatology|January 18, 2014
Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanomaJessica C Hassel, Philipp M Amann, Dirk Schadendorf, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2021
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology GroupImke Grimmelmann, Michael Momma, Lisa Zimmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanomaChristos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, et al.
Pageof 38